Efficacy of neurofeedback in treating ADD/ADHD

On January 22, the Potomac Institute for Policy Studies will present a guest lecture by Don DuRousseau, founder and CEO of Human Bionics LLC, a neurotechnology company specializing in brain-computer interface (BCI) systems. Mr. DuRousseau will explore the use of neurotechnology techniques, including the increasingly popular neurofeedback, as a treatment for ADD/ADHD. Many claims have been made about the efficacy of neurofeedback in treating these disorders. Mr. DuRousseau will address those claims and the risks that may be associated with misuse of the technology – including its application in new “mind-controlled” games and toys now on the market.

The program is sponsored by the Potomac Institute for Policy Studies in conjunction with the Capital Consortium for Neuroscience: Ethical, Legal and Social Issues (www.ccnelsi.com.) CCNELSI is under the direction of James Giordano, PhD, director of the Potomac Institute for Policy Studies’ Center for Neurotechnology Studies. More information about CNS and Dr. Giordano may be found at www.potomacinstitute.org and www.neurobioethics.org.